Evaluating the effect of givosiran (ALN-AS1) on the rate of porphyria attacks in patients with Acute Hepatic Porphyrias (AHP).

Trial Status: Enrolling

Interested in learning more? Please email us at [email protected]

For more info: ClinicalTrials.gov – NCT03338816